HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group - PubMed (original) (raw)
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group
T L Katzenstein et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997.
Abstract
The relations among serum HIV RNA levels, CD4 cell counts, presence of the mutant CCR5-allele in heterozygous form, and clinical outcome was analyzed in 96 patients from the Copenhagen AIDS Cohort. In the early years of the infection, patients with the CCR5 delta32/CCR5 genotype had significantly lower HIV RNA levels (p = 0.005) and higher CD4 cell counts (p < 0.005) than did patients homozygous for the normal allele. The long-term clinical benefit of being heterozygous is small and cannot solely explain the large interpatient variation in progression rates. The beneficial effect of being heterozygous seems to be mediated by events in the early stages of the HIV infection.
Similar articles
- MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
Bratt G, Leandersson AC, Albert J, Sandström E, Wahren B. Bratt G, et al. AIDS. 1998 May 7;12(7):729-36. doi: 10.1097/00002030-199807000-00009. AIDS. 1998. PMID: 9619804 - HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
Walli R, Reinhart B, Luckow B, Lederer E, Loch O, Malo A, Wank R, Schlöndorff D, Goebel FD. Walli R, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):229-33. doi: 10.1097/00042560-199807010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9665499 - Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L. Laurichesse JJ, et al. HIV Med. 2007 May;8(4):213-9. doi: 10.1111/j.1468-1293.2007.00455.x. HIV Med. 2007. PMID: 17461848 - Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK. Wang C, et al. J Infect Dis. 2014 Dec 1;210(11):1838-43. doi: 10.1093/infdis/jiu338. Epub 2014 Jun 16. J Infect Dis. 2014. PMID: 24935955 Free PMC article. - HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J, Rosińska M, Janiec J, Beniowski M, Cycoń M, Bratosiewicz-Wąsik J, Wąsik TJ. Smoleń-Dzirba J, et al. AIDS Rev. 2017 Dec;19(4):219-230. AIDS Rev. 2017. PMID: 28534889 Review.
Cited by
- Factors Influencing Immune Restoration in People Living with HIV/AIDS.
Aksak-Wąs BJ, Urbańska A, Scheibe K, Serwin K, Leszczyszyn-Pynka M, Rafalska-Kosior M, Gołąb J, Chober D, Parczewski M. Aksak-Wąs BJ, et al. J Clin Med. 2022 Mar 28;11(7):1887. doi: 10.3390/jcm11071887. J Clin Med. 2022. PMID: 35407496 Free PMC article. - Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.
Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S. Sherman KE, et al. Clin Infect Dis. 2019 May 17;68(11):1911-1918. doi: 10.1093/cid/ciy807. Clin Infect Dis. 2019. PMID: 30239650 Free PMC article. Clinical Trial. - Targeting CCR5 for anti-HIV research.
Gu WG, Chen XQ. Gu WG, et al. Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1881-7. doi: 10.1007/s10096-014-2173-0. Epub 2014 Jun 11. Eur J Clin Microbiol Infect Dis. 2014. PMID: 25027072 Review. - HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.
Prentice HA, Tang J. Prentice HA, et al. Viruses. 2012 Oct 10;4(10):2080-96. doi: 10.3390/v4102080. Viruses. 2012. PMID: 23202454 Free PMC article. Review. - Impact of ERCC2 gene polymorphism on HIV-1 disease progression to AIDS among North Indian HIV patients.
Sobti RC, Berhane N, Mahdi SA, Kler R, Hosseini SA, Kuttiat V, Wanchu A. Sobti RC, et al. Mol Biol Rep. 2011 Jun;38(5):2945-52. doi: 10.1007/s11033-010-9958-8. Epub 2010 Feb 2. Mol Biol Rep. 2011. PMID: 20127180
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials